Personalised Prostate Cancer Prevention is an up-to-date solution aimed at minimising the potential impact of prostate cancer by tailoring it to a man’s genetic risk level.
It begins with polygenic risk score testing (AntePC test), as polygenic risk score is the strongest independent risk factor for prostate cancer. Based on the test results, men receive personalised medical plans for screening and prevention.
This guidance includes when and how to initiate prostate cancer screening and other effective strategies to reduce personal risks. The service also includes a family history questionnaire for breast cancer, based on which it is determined whether the man requires additional testing for rare monogenic pathogenic variants (in genes such as BRCA1, BRCA2, etc.).
Armed with scientifically backed and well-documented medical advice, men can take preventive measures within their local healthcare system to protect their health proactively.
Recommended for men aged 40 and above.
